rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2000-7-31
|
pubmed:abstractText |
Bladder cancer is a frequently occurring tumour in Spain and usually affects elderly patients with renal impairment. The development of new combination therapies for such patients is thus of vital importance.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0030-2414
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2000 S. Karger AG, Basel
|
pubmed:issnType |
Print
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
24-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10895062-Aged,
pubmed-meshheading:10895062-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10895062-Blood Cells,
pubmed-meshheading:10895062-Carboplatin,
pubmed-meshheading:10895062-Carcinoma, Transitional Cell,
pubmed-meshheading:10895062-Deoxycytidine,
pubmed-meshheading:10895062-Female,
pubmed-meshheading:10895062-Humans,
pubmed-meshheading:10895062-Kidney Diseases,
pubmed-meshheading:10895062-Male,
pubmed-meshheading:10895062-Middle Aged,
pubmed-meshheading:10895062-Survival Analysis,
pubmed-meshheading:10895062-Urinary Bladder Neoplasms
|
pubmed:year |
2000
|
pubmed:articleTitle |
Carboplatin-gemcitabine treatment of patients with transitional cell carcinoma of the bladder and impaired renal function.
|
pubmed:affiliation |
Oncology Unit, Hospital del Mar-IMIM, Universitat Autònoma de Barcelona, Spain. 90604@imas.imim.es
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|